bromocriptine has been researched along with novobiocin in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Canko, A; Chan, SA; Gwee, CP; Kaplanai, E; Ki Chan, KW; Kiousis, D; Lescar, J; Luo, D; Matsoukas, MT; Rassias, G; Swarbrick, CMD; Vasudevan, SG; Wang, S; Zogali, V | 1 |
| Bernatchez, JA; Li, J; Li, R; Luan, Y; Siqueira-Neto, JL; Tran, LT | 1 |
| Nitsche, C; Voss, S | 1 |
2 review(s) available for bromocriptine and novobiocin
| Article | Year |
|---|---|
Drugs for the Treatment of Zika Virus Infection.
Topics: Animals; Antiviral Agents; Drug Development; Drug Discovery; Humans; Viral Vaccines; Zika Virus; Zika Virus Infection | 2020 |
Inhibitors of the Zika virus protease NS2B-NS3.
Topics: Animals; Antiviral Agents; Drug Discovery; Drug Repositioning; Humans; Serine Endopeptidases; Serine Proteinase Inhibitors; Viral Proteins; Zika Virus; Zika Virus Infection | 2020 |
3 other study(ies) available for bromocriptine and novobiocin
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Cell-active carbazole derivatives as inhibitors of the zika virus protease.
Topics: Antiviral Agents; Carbazoles; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Protease Inhibitors; RNA Helicases; Serine Endopeptidases; Structure-Activity Relationship; Viral Nonstructural Proteins; Zika Virus | 2019 |